Outcomes of Grade Group 2 and 3 Prostate Cancer on Initial Versus Confirmatory Biopsy: Implications for Active Surveillance.

Saved in:
Bibliographic Details
Title: Outcomes of Grade Group 2 and 3 Prostate Cancer on Initial Versus Confirmatory Biopsy: Implications for Active Surveillance.
Authors: Perera M; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Jibara G; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tin AL; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Haywood S; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sjoberg DD; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Benfante NE; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Carlsson SV; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Eastham JA; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Laudone V; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Touijer KA; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Fine S; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Scardino PT; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Vickers AJ; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ehdaie B; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: ehdaieb@mskcc.org.
Source: European urology focus [Eur Urol Focus] 2023 Jul; Vol. 9 (4), pp. 662-668. Date of Electronic Publication: 2022 Dec 23.
Publication Type: Review; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101665661 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-4569 (Electronic) Linking ISSN: 24054569 NLM ISO Abbreviation: Eur Urol Focus Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2405-4569
DOI:10.1016/j.euf.2022.12.008